It’s
not often that a drug’s product information sheet would be cause for
excitement, let alone celebration, writes AFAO Executive Director Darryl O'Donell.
Yet just as experts met in Sydney on 6 May to discuss HIV pre-exposure prophylaxis, Australia’s drug regulator quietly changed the product sheet for the drug Truvada to approve its use to prevent HIV.
Yet just as experts met in Sydney on 6 May to discuss HIV pre-exposure prophylaxis, Australia’s drug regulator quietly changed the product sheet for the drug Truvada to approve its use to prevent HIV.
This
change by Australia’s Therapeutic Goods Administration means that doctors can
now write a script for Truvada and it can be dispensed at a chemist. This is
groundbreaking because it means Australia’s drug technocrats have said that
Truvada is safe, and that it works in preventing sexual transmission of
HIV.
